WORK Medical subsidiary Neologics signs $114,000 service contract with GemPharmatech

Neologics Bioscience Inc., a subsidiary of WORK Medical Technology Group, has entered into a service agreement with GemPharmatech Corporation to provide testing services for $114,000. The services include material preparation, serum titer analysis, hybridoma fusion, antibody sequencing, and in vitro validation.

“Neologics has entered into a key service agreement with GemPharmatech Corporation to provide specified testing services for GemPharmatech.”globenewswire.com

• 1 source
• globenewswire.comWORK Medical Technology Group LTD’s Subsidiary Retains aWORK Medical Technology Group LTDNov 4, 2025

Summarized from public sources; check the original articles before acting on it.